United States · Telehealth platform · Brand-name and compounded
Gala Health review
Flat $179 a month for compounded tirzepatide at every dose — one of the few services where titrating up does not raise the bill.
Overview
Gala’s distinguishing term is dose-flat pricing: “$179/mo all doses, no hidden fees” for compounded GLP-1/GIP including tirzepatide, with a microdosing option at $149/month. Almost every competitor charges more as you titrate, so a flat rate through the escalation is a genuine structural difference rather than a marketing line.
It also lists brand-name Ozempic at $1,299/month — a retail cash price far above Novo’s own channel — and a Wegovy pill listed as coming soon. An alternative rate of “$199 per month (with a 3-month plan)” also appears, so confirm which plan the $179 attaches to.
Support is described as licensed providers in all 50 states, 24/7 support, and “async messaging with a licensed provider — get expert guidance anytime at no extra cost,” with personalised dosage adjustments included. Initial consultations may be synchronous or asynchronous; follow-ups run through chat. Gala states insurance is not required.
Medications and supply
Both. Gala describes its compounded products as not FDA-approved, and separately lists brand-name Ozempic.
- Compounded GLP-1/GIP including tirzepatide
- Microdosed compounded GLP-1/GIP
- Ozempic (semaglutide)
How the service works
- Consultation
- Initial consultation may be synchronous, such as a video visit, or asynchronous. Follow-ups run through the Gala chat.
- Eligibility
- Determined by a licensed provider.
- Provider involvement
- Licensed providers in all 50 states, 24/7 support, async messaging at no extra cost, and dosage adjustments included.
- Lab requirements
- Not stated in the sources we checked.
- Pharmacy fulfilment
- Not stated in the sources we checked.
- Shipping
- Not stated in the sources we checked.
- Support services
- 24/7 support, async provider messaging, side-effect guidance and dose adjustment.
What it costs
| Item | Published price | Notes |
|---|---|---|
| Compounded GLP-1/GIP | $179 / month | stated as all doses, no hidden fees |
| Microdosing GLP-1/GIP | $149 / month | — |
| Alternative plan rate | $199 / month | quoted with a 3-month plan |
| Ozempic | $1,299 / month | — |
- Membership fee
- Not stated separately.
- Medication fee
- Included in the monthly price for the compounded options.
- Insurance
- Not required — Gala states it does not require insurance.
- HSA / FSA
- Not stated in the sources we checked.
- Cancellation
- Not stated in the sources we checked.
- Refunds
- Not stated in the sources we checked.
Pros
- Flat pricing across all doses, so titrating up does not raise the bill
- Async provider messaging included at no extra cost
- Dose adjustments explicitly included
- Licensed providers in all 50 states
Cons
- Two different headline rates appear — $179 and $199 with a 3-month plan
- Ozempic at $1,299/month is far above the manufacturer channel
- Nothing published on labs, shipping, cancellation or refunds
Who it may suit
Someone who expects to titrate to a high dose and wants the price fixed before they get there.
Limitations
- Compounded products are not FDA-approved
- Confirm which plan length the $179 rate applies to before ordering
Questions
Does the price really stay the same at higher doses?
Gala states “$179/mo all doses, no hidden fees” for its compounded GLP-1/GIP. That is unusual — most services in this research charge more as you titrate. Confirm it against the plan you are offered at checkout.
Is Ozempic worth $1,299 here?
That is a retail cash price. Novo Nordisk publishes self-pay Wegovy from $149/month through NovoCare, and Ozempic is the diabetes brand rather than the weight one.
Sources
Everything on this page traces to one of the links below, retrieved on the date shown. Prices and programme terms in this market change without notice — confirm against the provider before you buy.
- 01Gala Health — dose-flat pricing, support model, insurance stanceretrieved 2026-08-15